2024 Q2 Form 10-Q Financial Statement

#000093454924000046 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $25.84M $24.32M
YoY Change 226.9% 64.29%
Cost Of Revenue $19.08M $12.37M
YoY Change 113.35% 24.17%
Gross Profit $6.758M $11.96M
YoY Change -750.43% 146.75%
Gross Profit Margin 26.16% 49.16%
Selling, General & Admin $11.34M $13.91M
YoY Change 0.47% -0.32%
% of Gross Profit 167.77% 116.34%
Research & Development $178.0K $134.0K
YoY Change -13.17% -37.96%
% of Gross Profit 2.63% 1.12%
Depreciation & Amortization $7.405M $4.568M
YoY Change 117.28% 35.11%
% of Gross Profit 109.57% 38.21%
Operating Expenses $11.52M $14.04M
YoY Change 0.23% -0.9%
Operating Profit -$4.758M -$2.087M
YoY Change -62.02% -77.62%
Interest Expense -$4.519M $7.032M
YoY Change -42.76% -66.91%
% of Operating Profit
Other Income/Expense, Net -$11.13M $789.0K
YoY Change 41.0% -96.29%
Pretax Income -$15.89M -$1.298M
YoY Change -22.2% -110.88%
Income Tax -$7.061M -$1.109M
% Of Pretax Income
Net Earnings -$8.446M -$186.0K
YoY Change -55.02% -101.97%
Net Earnings / Revenue -32.69% -0.76%
Basic Earnings Per Share -$0.08 $0.00
Diluted Earnings Per Share -$0.08 $0.00
COMMON SHARES
Basic Shares Outstanding 100.0M shares 99.90M shares
Diluted Shares Outstanding 100.1M shares 99.75M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $441.9M $498.4M
YoY Change -0.65% 7.96%
Cash & Equivalents $387.0M $438.8M
Short-Term Investments $54.92M $59.67M
Other Short-Term Assets $20.96M $29.47M
YoY Change 1.12% 46.6%
Inventory $12.29M $9.880M
Prepaid Expenses
Receivables $18.77M $15.37M
Other Receivables $0.00 $0.00
Total Short-Term Assets $493.9M $553.1M
YoY Change 1.68% 9.49%
LONG-TERM ASSETS
Property, Plant & Equipment $2.315M $2.090M
YoY Change -21.53% -36.18%
Goodwill $8.990M $8.990M
YoY Change 19.21% 19.21%
Intangibles $36.02M $29.69M
YoY Change 17.74% -11.7%
Long-Term Investments $30.93M $30.93M
YoY Change 0.0% 0.0%
Other Assets $4.257M $4.572M
YoY Change -38.53% -14.69%
Total Long-Term Assets $259.7M $78.58M
YoY Change 430.83% 52.84%
TOTAL ASSETS
Total Short-Term Assets $493.9M $553.1M
Total Long-Term Assets $259.7M $78.58M
Total Assets $753.6M $631.7M
YoY Change 40.94% 13.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.191M $4.702M
YoY Change -44.88% -44.11%
Accrued Expenses $32.40M $15.75M
YoY Change 259.08% 0.4%
Deferred Revenue $911.0K $1.069M
YoY Change -10.86% -11.36%
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.20M $25.85M
YoY Change -43.19% -71.35%
LONG-TERM LIABILITIES
Long-Term Debt $82.00M $13.03M
YoY Change
Other Long-Term Liabilities $1.479M $1.417M
YoY Change -20.4% -15.35%
Total Long-Term Liabilities $1.479M $1.417M
YoY Change -20.4% -15.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.20M $25.85M
Total Long-Term Liabilities $1.479M $1.417M
Total Liabilities $156.8M $42.12M
YoY Change -10.94% -76.53%
SHAREHOLDERS EQUITY
Retained Earnings -$248.4M -$239.9M
YoY Change -21.43% -19.31%
Common Stock $100.0K $100.0K
YoY Change 72.41% 72.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $98.26M $98.26M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $560.7M $568.3M
YoY Change
Total Liabilities & Shareholders Equity $753.6M $631.7M
YoY Change 40.94% 13.5%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$8.446M -$186.0K
YoY Change -55.02% -101.97%
Depreciation, Depletion And Amortization $7.405M $4.568M
YoY Change 117.28% 35.11%
Cash From Operating Activities $16.12M $54.84M
YoY Change -209.09% -1360.96%
INVESTING ACTIVITIES
Capital Expenditures $151.9M $270.0K
YoY Change 281146.3% 225.3%
Acquisitions
YoY Change
Other Investing Activities $0.00 $42.31M
YoY Change -100.0% 1376.27%
Cash From Investing Activities -$151.9M $42.04M
YoY Change -2460.11% 1410.6%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 84.05M $1.826M
YoY Change -12589.45% -97.66%
NET CHANGE
Cash From Operating Activities 16.12M $54.84M
Cash From Investing Activities -151.9M $42.04M
Cash From Financing Activities 84.05M $1.826M
Net Change In Cash -51.70M $98.67M
YoY Change 473.78% 29.08%
FREE CASH FLOW
Cash From Operating Activities $16.12M $54.84M
Capital Expenditures $151.9M $270.0K
Free Cash Flow -$135.8M $54.57M
YoY Change 815.61% -1331.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
3011000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1069000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
977000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
356000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
458000 usd
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2024Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q4 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
10786000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
8450000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24320000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14803000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
134000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1555000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1913000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12353000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12040000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
26407000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
24127000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2087000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9324000 usd
CY2024Q1 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-26701000 usd
CY2023Q1 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
3343000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
28861000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-1361000 usd
CY2024Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
2160000 usd
CY2023Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
1982000 usd
CY2024Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
6243000 usd
CY2023Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
16651000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
80000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
900000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4890000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3441000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
789000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21254000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1298000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11930000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1109000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2483000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-189000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
9447000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-186000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9447000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-186000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5958000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99745905 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47971931 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-186000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6496000 usd
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
99745905 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
89067821 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589609000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-189000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
674000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
858000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589604000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
269322000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9447000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
1554000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
700000 usd
CY2023Q1 actg Issuance Of Common Stock From The Rights Offering
IssuanceOfCommonStockFromTheRightsOffering
79111000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
416000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
477000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355687000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-189000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
9447000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4568000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3381000 usd
CY2024Q1 actg Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
0 usd
CY2023Q1 actg Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
5023000 usd
CY2024Q1 actg Unrealized Gain Loss On Derivatives1
UnrealizedGainLossOnDerivatives1
0 usd
CY2023Q1 actg Unrealized Gain Loss On Derivatives1
UnrealizedGainLossOnDerivatives1
11628000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
858000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
477000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-18000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
80000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-26701000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
3343000 usd
CY2024Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
28861000 usd
CY2023Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-1361000 usd
CY2024Q1 actg Gain On Sale Of Prepaid Investment And Derivative
GainOnSaleOfPrepaidInvestmentAndDerivative
-629000 usd
CY2023Q1 actg Gain On Sale Of Prepaid Investment And Derivative
GainOnSaleOfPrepaidInvestmentAndDerivative
0 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3652000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-240000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-65156000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
451000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1041000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
503000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10752000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
391000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7108000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2355000 usd
CY2024Q1 actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
-7811000 usd
CY2023Q1 actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
360000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
25000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-71000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
54839000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4349000 usd
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15544000 usd
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5166000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
57854000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
8032000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
270000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
42040000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2783000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2500000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
700000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
674000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
416000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1826000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77995000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-34000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
98671000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
76441000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
340091000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
287786000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438762000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
364227000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
319000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
116000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
147000 usd
CY2024Q1 actg Patent Acquisition Accrued Liability Long Term
PatentAcquisitionAccruedLiabilityLongTerm
-4000000 usd
CY2023Q1 actg Patent Acquisition Accrued Liability Long Term
PatentAcquisitionAccruedLiabilityLongTerm
6000000 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61123595 shares
CY2024Q1 actg Number Of Patent Portfolios Acquired
NumberOfPatentPortfoliosAcquired
0 patent
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
470000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
567000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.85
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.20
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
757000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
19971000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
2966000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
19000 usd
CY2024Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
22918000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
33423000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
29680000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
35000 usd
CY2023Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
63068000 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3404000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3961000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1533000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1882000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5447000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5578000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
10384000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
11421000 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
504000 usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
500000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
9880000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10921000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4728000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4760000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2638000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2404000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2090000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2356000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
280000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
347000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q1 actg Accelerated Amortization Of Patents
AcceleratedAmortizationOfPatents
0 usd
CY2024Q1 actg Accelerated Amortization Of Patents
AcceleratedAmortizationOfPatents
0 usd
CY2024Q1 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
25533000 usd
CY2023Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
25276000 usd
CY2024Q1 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
581000 usd
CY2023Q4 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
159000 usd
CY2024Q1 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
24952000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
25117000 usd
CY2024Q1 actg Oil And Gas Depreciation And Depletion Expense
OilAndGasDepreciationAndDepletionExpense
422000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
8990000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 us-gaap Goodwill
Goodwill
8990000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
7541000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1449000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
8990000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
353533000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
323843000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29690000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
353533000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
319977000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
33556000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
10964000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12485000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3173000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1734000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1334000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29690000 usd
CY2024Q1 actg Accrued Patent Investment Costs
AccruedPatentInvestmentCosts
15000000 usd
CY2023Q4 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
4000000 usd
CY2024Q1 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
0 usd
CY2023Q4 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
4000000 usd
CY2024Q1 actg Accrued Consulting And Other Professional Fees
AccruedConsultingAndOtherProfessionalFees
832000 usd
CY2023Q4 actg Accrued Consulting And Other Professional Fees
AccruedConsultingAndOtherProfessionalFees
1595000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1313000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
619000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
27000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
30000 usd
CY2024Q1 actg Service Contract Costs Accrued Current
ServiceContractCostsAccruedCurrent
168000 usd
CY2023Q4 actg Service Contract Costs Accrued Current
ServiceContractCostsAccruedCurrent
169000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1094000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1248000 usd
CY2024Q1 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
0 usd
CY2023Q4 actg Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
4000000 usd
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
556000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
744000 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3990000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
8405000 usd
CY2023Q3 actg Class Of Warrant Or Right Gross Proceeds Recapitalization Payment
ClassOfWarrantOrRightGrossProceedsRecapitalizationPayment
55000000 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61123595 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99886322 shares
CY2023Q3 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
27704 shares
CY2023Q3 actg Class Of Warrant Or Right Gross Proceeds Recapitalization Payment
ClassOfWarrantOrRightGrossProceedsRecapitalizationPayment
55000000 usd
CY2023Q3 actg Class Of Warrant Or Right Recapitalization Payment
ClassOfWarrantOrRightRecapitalizationPayment
66000000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
2100000 usd
CY2024Q1 us-gaap Legal Fees
LegalFees
0 usd
CY2023Q1 us-gaap Legal Fees
LegalFees
20000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
336000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
388000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
825000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
924000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
579000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
243000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2571000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1094000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1477000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
40000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2024Q1 actg Ownership Percent Of Voting Stock
OwnershipPercentOfVotingStock
0.10
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1369000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
420000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4300000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y9M18D
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-186000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9447000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
700000 usd
CY2024Q1 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 usd
CY2023Q1 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1554000 usd
CY2024Q1 us-gaap Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic
UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
0 usd
CY2023Q1 us-gaap Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic
UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
1235000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-186000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5958000 usd
CY2024Q1 actg Dividend On Series A Redeemable Convertible Preferred Stock
DividendOnSeriesARedeemableConvertiblePreferredStock
0 usd
CY2023Q1 actg Dividend On Series A Redeemable Convertible Preferred Stock
DividendOnSeriesARedeemableConvertiblePreferredStock
700000 usd
CY2024Q1 actg Accretion Of Series A Redeemable Convertible Preferred Stock
AccretionOfSeriesARedeemableConvertiblePreferredStock
0 usd
CY2023Q1 actg Accretion Of Series A Redeemable Convertible Preferred Stock
AccretionOfSeriesARedeemableConvertiblePreferredStock
1554000 usd
CY2024Q1 actg Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative
0 usd
CY2023Q1 actg Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative
5023000 usd
CY2024Q1 actg Change In Fair Value Of Dilutive Series B Warrants
ChangeInFairValueOfDilutiveSeriesBWarrants
0 usd
CY2023Q1 actg Change In Fair Value Of Dilutive Series B Warrants
ChangeInFairValueOfDilutiveSeriesBWarrants
11628000 usd
CY2024Q1 actg Interest Expense Associated With Starboard Notes Net Of Tax
InterestExpenseAssociatedWithStarboardNotesNetOfTax
0 usd
CY2023Q1 actg Interest Expense Associated With Starboard Notes Net Of Tax
InterestExpenseAssociatedWithStarboardNotesNetOfTax
708000 usd
CY2024Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1235000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-186000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6496000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99745905 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47971931 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99745905 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89067821 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4231699 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2368870 shares
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24320000 usd
CY2024Q1 us-gaap Royalty Expense
RoyaltyExpense
606000 usd
CY2024Q1 actg Contingent Legal Fees
ContingentLegalFees
1824000 usd
CY2024Q1 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
1138000 usd
CY2024Q1 actg Amortization Of Patents
AmortizationOfPatents
3433000 usd
CY2024Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
4049000 usd
CY2024Q1 us-gaap Production Costs
ProductionCosts
1315000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
12365000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
11955000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2087000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
789000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1298000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14803000 usd
CY2023Q1 us-gaap Royalty Expense
RoyaltyExpense
221000 usd
CY2023Q1 actg Contingent Legal Fees
ContingentLegalFees
532000 usd
CY2023Q1 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
1384000 usd
CY2023Q1 actg Amortization Of Patents
AmortizationOfPatents
2601000 usd
CY2023Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
5220000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
9958000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
4845000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9324000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21254000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11930000 usd
CY2024Q1 actg Trading Securities Fair Value Disclosure
TradingSecuritiesFairValueDisclosure
22918000 usd
CY2023Q4 actg Trading Securities Fair Value Disclosure
TradingSecuritiesFairValueDisclosure
63068000 usd
CY2024Q1 us-gaap Trading Securities Debt
TradingSecuritiesDebt
5816000 usd
CY2023Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
5816000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
30934000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
30934000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
59668000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
99818000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
261185000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
218909000 usd
CY2024Q1 us-gaap Assets
Assets
631725000 usd
CY2023Q4 us-gaap Assets
Assets
633545000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24320000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14803000 usd
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
27042000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
27473000 usd

Files In Submission

Name View Source Status
0000934549-24-000046-index-headers.html Edgar Link pending
0000934549-24-000046-index.html Edgar Link pending
0000934549-24-000046.txt Edgar Link pending
0000934549-24-000046-xbrl.zip Edgar Link pending
actg-20240331.htm Edgar Link pending
actg-20240331.xsd Edgar Link pending
actg-20240331xex311.htm Edgar Link pending
actg-20240331xex312.htm Edgar Link pending
actg-20240331xex321.htm Edgar Link pending
actg-20240331xex322.htm Edgar Link pending
actg-20240331_cal.xml Edgar Link unprocessable
actg-20240331_def.xml Edgar Link unprocessable
actg-20240331_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
actg-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
actg-20240331_lab.xml Edgar Link unprocessable